Chapter 031

Procoagulant, Anticoagulant, and Thrombolytic Drugs

Barton S. Johnson

CITED REFERENCES

  1. Andrews RK, Berndt MC: Platelet adhesion: a game of catch and release. J Clin Invest 118:3009-3011, 2008. PUBMED Abstract
  2. Beirne OR, Koehler JR: Surgical management of patients on warfarin sodium. J Oral Maxillofac Surg 54:1115-1118, 1996.PUBMED Abstract
  3. Bick RL: Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemost 14:299-338, 1988. PUBMED Abstract
  4. Blockmans D, Deckmyn H, Vermylen J: Platelet activation. Blood Rev 9:143-156, 1995.PUBMED Abstract
  5. Brennan M: Fibrin glue. Blood Rev 5:240-244, 1991. PUBMED Abstract
  6. Brennan MT, Valerin MA, Noll JL, et al: Aspirin use and post-operative bleeding from dental extractions. J Dent Res 87:740-744, 2008. PUBMED Abstract
  7. Campbell J, Alvarado F, Murray RA: Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered? J Oral Maxillofac Surg 58:131-135, 2000. PUBMED Abstract
  8. Catella-Lawson F, Reilly MD, Kapoor SC, et al: Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809-1817, 2001. PUBMED Abstract
  9. Collen D, Topol EJ, Tiefenbrunn AJ, et al: Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 70:1012-1017, 1984. PUBMED Abstract
  10. Devani P, Lavery KM, Howell CJ: Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 36:107-111, 1998. PUBMED Abstract
  11. Eriksson B, Bauer KA, Lassen MR, et al: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 345:1298-1304, 2001. PUBMED Abstract
  12. Esmon CT: The regulation of natural anticoagulant pathways. Science 235:1348-1352, 1987.PUBMED Abstract
  13. Frydman A: Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics, and metabolism in humans. Haemostasis 26(Suppl 2):24-38, 1996.PUBMED Abstract
  14. Gachet C: ADP receptors of platelets and their inhibition. Thromb Haemost 86:222-232, 2001. PUBMED Abstract
  15. Ginsburg D, Bowie EJW: Molecular genetics of von Willebrand disease. Blood 79:2507-2519, 1992. PUBMED Abstract
  16. Grines CL, Bonow RO, Casey DE Jr: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc 138:652-655, 2007. PUBMED Abstract
  17. Hammeke M: Heparin-induced thrombocytopenia type II: criteria for diagnosis and options for treatment. University of Washington Drug Therapy Topics 31:11-16, 2002.
  18. Harrison P, Cramer EM: Platelet α-granules. Blood Rev 7:52-62, 1993. PUBMED Abstract
  19. Hazinski MF, Cummins RO, Field JM, editors: 2008 handbook of emergency cardiac care for healthcare providers, Dallas, 2008, American Heart Association.
  20. Jeske AH, Suchko GD: Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 143:1492-1497, 2003.PUBMED Abstract
  21. Jolly DW, Craig C, Nelson TE Jr: Estrogen and prothrombin synthesis: effect of estrogen on absorption of vitamin K1. Am J Physiol 232:H12-H17, 1977. PUBMED Abstract
  22. Kearon C, Hirsch J: Management of anticoagulation before and after elective surgery. N Engl J Med 336:1506-1511, 1997. PUBMED Abstract
  23. Landis RC, Haskard DO, Taylor KM: New anti-inflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 72:S1808-S1813, 2001. PUBMED Abstract
  24. Lemon RR, Steele PJ, Jeansonne BG: Ferric sulfate hemostasis: effect on osseous wound healing, I: left in situ for maximum exposure. J Endod 19:170-173, 1993. PUBMED Abstract
  25. Macik BG: Treatment of factor VIII inhibitors: products and strategies. Semin Thromb Hemost 19:13-24, 1993. PUBMED Abstract
  26. Parise LV, Smyth SS, Shet AS, et al: Platelet morphology, biochemistry, and function. In Lichtman MA, Beutler E, Kipps TJ, et al, editors: Williams hematology, ed 7, New York, 2006, McGraw-Hill.
  27. Rakocz M, Mazar A, Varon D, et al: Dental extractions in patients with bleeding disorders: the use of fibrin glue. Oral Surg Oral Med Oral Pathol 75:280-282, 1993. PUBMED Abstract
  28. Ramana RK, Lewis BE: Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin. Vasc Health Risk Manag 4:493-505, 2008. PUBMED Abstract
  29. Ranjadayalan K, Umachandran V, Timmis AD: Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit. Am J Med 92:233-238, 1992. PUBMED Abstract
  30. Smith JB, Theakston RD, Coelho AL, et al: Characterization of a monomeric disintegrin, ocellatusin, present in the venom of the Nigerian carpet viper. Echis ocellatus, FEBS Lett 512:111-115, 2002. PUBMED Abstract
  31. Thompson AR: Factor IX concentrates for clinical use. Semin Thromb Hemost 19:25-36, 1993. PUBMED Abstract
  32. Thompson AR: Molecular biology of the hemophilias. Prog Hemost Thromb 10:175-214, 1991. PUBMED Abstract
  33. Thompson AR: Recombinant factor IX for the treatment of hemophilia B. Semin Hematol 35(suppl 2):1-3, 1998. PUBMED Abstract
  34. Todd D, Roman A: Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: case report. J Oral Maxillofac Surg 59:1090-1092, 2001.PUBMED Abstract
  35. Wohner N: Role of cellular elements in thrombus formation and dissolution. Cardiovasc Hematol Agents Med Chem 6:224-228, 2008. PUBMED Abstract
  36. Woody RD, Miller A, Staffanou RS: Review of the pH of hemostatic agents used in tissue displacement. J Prosthet Dent 70:191-192, 1993. PUBMED Abstract

GENERAL REFERENCES

  1. AHFS drug information 2009, Bethesda, MD, 2009, American Society of Health-System Pharmacists.
  2. Hillman RS, Ault KA, Rinder H: Hematology in clinical practice, ed 4, New York, 2005, McGraw-Hill.
  3. Lichtman MA, Beutler E, Kipps TJ, et al, editors: Williams hematology, ed 7, New York, 2006, McGraw-Hill.
  4. Majerus PW, Tollefesen DM: Blood coagulation and anticoagulant, thrombolytic, and antiplatelet drugs. In Brunton LL, Lazo JS, Parker KL, editors: Goodman & Gillman’s the pharmacological basis of therapeutics, ed 11, New York, 2006, McGraw-Hill.
  5. McPhee SJ, Papadakis MA, editors: Current medical diagnosis and treatment 2009, ed 48, Stamford, CT, 2009, Lange Medical Books/McGraw-Hill.